Federated Hermes’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Buy
+202,040
New +$2.17M ﹤0.01% 941
2025
Q2
Sell
-12,923
Closed -$311K 2071
2025
Q1
$311K Buy
12,923
+170
+1% +$6K ﹤0.01% 1416
2024
Q4
$476K Sell
12,753
-8,869
-41% -$414K ﹤0.01% 1325
2024
Q3
$1.08M Sell
21,622
-2,233
-9% -$86.9K ﹤0.01% 1092
2024
Q2
$828K Sell
23,855
-39,287
-62% -$1.55M ﹤0.01% 1171
2024
Q1
$3.45M Buy
63,142
+53,244
+538% +$2.64M 0.01% 807
2023
Q4
$424K Buy
+9,898
New +$308K ﹤0.01% 1381
2023
Q3
Sell
-115,194
Closed -$2.76M 2104
2023
Q2
$2.76M Buy
115,194
+109,001
+1,760% +$1.88M 0.01% 857
2023
Q1
$84.6K Buy
6,193
+1,832
+42% +$29.2K ﹤0.01% 1685
2022
Q4
$60.5K Buy
+4,361
New +$61.6K ﹤0.01% 1695

Other funds holding BHVN

Federated Hermes's BHVN Position: Q2 2026 in Review

Federated Hermes opened a new position in Biohaven (BHVN) in Q2 2026: 202,040 shares worth $3.01M. The stake represents ﹤0.01% of the portfolio and ranks #941 among its holdings. This is a return to the name: Federated Hermes previously reported a position in BHVN as recently as Q1 2025.

Federated Hermes first reported a position in BHVN in Q4 2022 and has held it in 10 quarters since. The position peaked at $3.45M in Q1 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Federated Hermes held 202,040 shares of Biohaven worth $3.01M as of Q2 2026.
  • Biohaven was a new Federated Hermes position in Q2 2026.
  • Biohaven made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #941 holding.
  • Federated Hermes first reported a position in Biohaven in Q4 2022 and has held it in 10 quarters since.
  • Federated Hermes's Biohaven position peaked at $3.45M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.